Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
Yearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influe...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2071061 |
_version_ | 1797673212899753984 |
---|---|
author | Yuting Liao Yan Jin Hangjie Zhang Juan Yang Jian Fu Huakun Lv |
author_facet | Yuting Liao Yan Jin Hangjie Zhang Juan Yang Jian Fu Huakun Lv |
author_sort | Yuting Liao |
collection | DOAJ |
description | Yearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influenza vaccine (TIV) in adults aged ≥60 years during the 2018–2019 season in Taizhou City, Zhejiang Province in China. A total of 422 participants completed the study period. Vaccinated participants (284) received a single dose of TIV, but unvaccinated participants (138) didn’t receive any vaccine. Study participants vaccinated with TIV had significantly higher GMTs of Hemagglutination Inhibition (HI) antibodies against AH1N1, AH2N3, and B/Victoria strains (all p < .0001) at day 30 post-vaccination compared with unvaccinated participants, but the antibody response to the B/Victoria strain was the weakest. Rates of seroprotection and seroconversion were generally higher in the TIV-vaccinated group. At day 180 post-vaccination, the seroconversion rates (95%CI) in the vaccinated group were 99.6% (99.0%–100.3%), 97.9% (96.2%–99.6%), and 68.3% (62.9%–73.8%) for antibodies against three influenza strains, respectively; these rates were significantly different compared with unvaccinated group only for strains AH3N2 and B/Victoria (p = .002 and p < .0001, respectively). These results confirm that in adults aged ≥60 years, a single dose of TIV can induce a protective immune response against influenza, but the protective HI antibody levels induced against strain B/Victoria do not persist through 6 months. |
first_indexed | 2024-03-11T21:41:13Z |
format | Article |
id | doaj.art-ee3b08eddc394d308ea0f271fe174c63 |
institution | Directory Open Access Journal |
issn | 2164-5515 2164-554X |
language | English |
last_indexed | 2024-03-11T21:41:13Z |
publishDate | 2022-11-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj.art-ee3b08eddc394d308ea0f271fe174c632023-09-26T13:19:06ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20710612071061Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 seasonYuting Liao0Yan Jin1Hangjie Zhang2Juan Yang3Jian Fu4Huakun Lv5Xiamen UniversityTaizhou Municipal Center for Disease Control and PreventionZhejiang Provincial Center for Disease Control and PreventionXiamen UniversityZhejiang Provincial Center for Disease Control and PreventionZhejiang Provincial Center for Disease Control and PreventionYearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influenza vaccine (TIV) in adults aged ≥60 years during the 2018–2019 season in Taizhou City, Zhejiang Province in China. A total of 422 participants completed the study period. Vaccinated participants (284) received a single dose of TIV, but unvaccinated participants (138) didn’t receive any vaccine. Study participants vaccinated with TIV had significantly higher GMTs of Hemagglutination Inhibition (HI) antibodies against AH1N1, AH2N3, and B/Victoria strains (all p < .0001) at day 30 post-vaccination compared with unvaccinated participants, but the antibody response to the B/Victoria strain was the weakest. Rates of seroprotection and seroconversion were generally higher in the TIV-vaccinated group. At day 180 post-vaccination, the seroconversion rates (95%CI) in the vaccinated group were 99.6% (99.0%–100.3%), 97.9% (96.2%–99.6%), and 68.3% (62.9%–73.8%) for antibodies against three influenza strains, respectively; these rates were significantly different compared with unvaccinated group only for strains AH3N2 and B/Victoria (p = .002 and p < .0001, respectively). These results confirm that in adults aged ≥60 years, a single dose of TIV can induce a protective immune response against influenza, but the protective HI antibody levels induced against strain B/Victoria do not persist through 6 months.http://dx.doi.org/10.1080/21645515.2022.2071061seasonal influenzavaccinetrivalentimmunogenicitypersistence of immunityelderly |
spellingShingle | Yuting Liao Yan Jin Hangjie Zhang Juan Yang Jian Fu Huakun Lv Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season Human Vaccines & Immunotherapeutics seasonal influenza vaccine trivalent immunogenicity persistence of immunity elderly |
title | Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season |
title_full | Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season |
title_fullStr | Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season |
title_full_unstemmed | Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season |
title_short | Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season |
title_sort | immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in taizhou city zhejiang province china during the 2018 2019 season |
topic | seasonal influenza vaccine trivalent immunogenicity persistence of immunity elderly |
url | http://dx.doi.org/10.1080/21645515.2022.2071061 |
work_keys_str_mv | AT yutingliao immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season AT yanjin immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season AT hangjiezhang immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season AT juanyang immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season AT jianfu immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season AT huakunlv immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season |